Cargando…

Editorial: Precision/Personalized Pediatric Oncology and Immune Therapies: Rather Customize Than Randomize

Detalles Bibliográficos
Autores principales:	Kýr, Michal, Klement, Giannoula Lakka, Zdrazilova-Dubska, Lenka, Demlova, Regina, Valik, Dalibor, Slaby, Ondrej, Slavc, Irene, Sterba, Jaroslav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7109439/ https://www.ncbi.nlm.nih.gov/pubmed/32269965 http://dx.doi.org/10.3389/fonc.2020.00377

Ejemplares similares

Minimal Residual Disease–Guided Intermittent Dosing in Patients With Cancer: Successful Treatment of Chemoresistant Anaplastic Large Cell Lymphoma Using Intermittent Lorlatinib Dosing
por: Pokorna, Petra, et al.
Publicado: (2022)

Role of platelet chemokines, PF-4 and CTAP-III, in cancer biology
por: Pilatova, Katerina, et al.
Publicado: (2013)

Future paradigms for precision oncology
por: Klement, Giannoula Lakka, et al.
Publicado: (2016)

Comprehensive Molecular Profiling for Relapsed/Refractory Pediatric Burkitt Lymphomas—Retrospective Analysis of Three Real-Life Clinical Cases—Addressing Issues on Randomization and Customization at the Bedside
por: Polaskova, Kristyna, et al.
Publicado: (2020)

B-Cell Activating Factor as a Cancer Biomarker and Its Implications in Cancer-Related Cachexia
por: Rihacek, Michal, et al.
Publicado: (2015)

Individualization of Treatment Improves the Survival of Children With High-Risk Solid Tumors: Comparative Patient Series Analysis in a Real-Life Scenario
por: Kyr, Michal, et al.
Publicado: (2019)

Assessment of Immune Response Following Dendritic Cell-Based Immunotherapy in Pediatric Patients With Relapsing Sarcoma
por: Fedorova, Lenka, et al.
Publicado: (2019)

Dendritic Cell-Based Immunotherapy in Advanced Sarcoma and Neuroblastoma Pediatric Patients: Anti-cancer Treatment Preceding Monocyte Harvest Impairs the Immunostimulatory and Antigen-Presenting Behavior of DCs and Manufacturing Process Outcome
por: Hlavackova, Eva, et al.
Publicado: (2019)

Efficacy of bevacizumab and chemotherapy in the first-line treatment of metastatic colorectal cancer: broadening KRAS-focused clinical view
por: Bencsikova, Beatrix, et al.
Publicado: (2015)

Circulating T cell subsets are associated with clinical outcome of anti-VEGF-based 1st-line treatment of metastatic colorectal cancer patients: a prospective study with focus on primary tumor sidedness
por: Bencsikova, Beatrix, et al.
Publicado: (2019)

Phospho-Protein Arrays as Effective Tools for Screening Possible Targets for Kinase Inhibitors and Their Use in Precision Pediatric Oncology
por: Neradil, Jakub, et al.
Publicado: (2019)

Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-Trans Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
por: Paukovcekova, Silvia, et al.
Publicado: (2020)

LightCycler SeptiFast technology in patients with solid malignancies: clinical utility for rapid etiologic diagnosis of sepsis
por: Dubská, Lenka, et al.
Publicado: (2012)

MicroRNA-Based Therapy in Animal Models of Selected Gastrointestinal Cancers
por: Merhautova, Jana, et al.
Publicado: (2016)

Platelet Proteome and Tumor Dormancy: Can Platelets Content Serve as Predictive Biomarkers for Exit of Tumors from Dormancy?
por: Almog, Nava, et al.
Publicado: (2010)

Adjustment of serum HE4 to reduced glomerular filtration and its use in biomarker-based prediction of deep myometrial invasion in endometrial cancer
por: Chovanec, Josef, et al.
Publicado: (2017)

Personalized Treatment of H3K27M-Mutant Pediatric Diffuse Gliomas Provides Improved Therapeutic Opportunities
por: Gojo, Johannes, et al.
Publicado: (2020)

1563MO CoVigi phase IV multicentric trial evaluating COVID-19 vaccination adverse events and immune response dynamics in cancer patients: First results on antibody and cellular immunity
por: Obermannova, R., et al.
Publicado: (2021)

Sunitinib-Induced Elevation of Mean Corpuscular Volume (MCV)—Exploring Its Possible Clinical Relevance in Cancer Patients
por: Rihacek, Michal, et al.
Publicado: (2022)

miR-155 and miR-484 Are Associated with Time to Progression in Metastatic Renal Cell Carcinoma Treated with Sunitinib
por: Merhautova, Jana, et al.
Publicado: (2015)

Assessment of Tumor Mutational Burden in Pediatric Tumors by Real-Life Whole-Exome Sequencing and In Silico Simulation of Targeted Gene Panels: How the Choice of Method Could Affect the Clinical Decision?
por: Noskova, Hana, et al.
Publicado: (2020)

PET/CT-tailored treatment of locally advanced oesophago-gastric junction adenocarcinoma: a report on the feasibility of the multicenter GastroPET study
por: Obermannova, Radka, et al.
Publicado: (2022)

Design principles for cancer therapy guided by changes in complexity of protein-protein interaction networks
por: Benzekry, Sebastian, et al.
Publicado: (2015)

Gibbs Energy and Gene Expression Combined as a New Technique for Selecting Drug Targets for Inhibiting Specific Protein–Protein Interactions
por: Rietman, Edward A., et al.
Publicado: (2023)

Improved osteosarcoma survival with addition of mifamurtide to conventional chemotherapy – Observational prospective single institution analysis
por: Múdry, Peter, et al.
Publicado: (2021)

Normal Wound Healing and Tumor Angiogenesis as a Game of Competitive Inhibition
por: Kareva, Irina, et al.
Publicado: (2016)

Personalized anticancer therapy selection using molecular landscape topology and thermodynamics
por: Rietman, Edward A., et al.
Publicado: (2016)

Hidden threat of tortoise ticks: high prevalence of Crimean-Congo haemorrhagic fever virus in ticks Hyalomma aegyptium in the Middle East
por: Široký, Pavel, et al.
Publicado: (2014)

DHFR-mediated effects of methotrexate in medulloblastoma and osteosarcoma cells: The same outcome of treatment with different doses in sensitive cell lines
por: NERADIL, JAKUB, et al.
Publicado: (2015)

Molecular portraits of colorectal cancer morphological regions
por: Budinská, Eva, et al.
Publicado: (2023)

Personalized therapy design for systemic lupus erythematosus based on the analysis of protein-protein interaction networks
por: Brant, Elizabeth J., et al.
Publicado: (2020)

Comparative Analysis of Putative Prognostic and Predictive Markers in Neuroblastomas: High Expression of PBX1 Is Associated With a Poor Response to Induction Therapy
por: Veselska, Renata, et al.
Publicado: (2019)

Genome‐wide identification of urinary cell‐free microRNAs for non‐invasive detection of bladder cancer
por: Juracek, Jaroslav, et al.
Publicado: (2018)

I would rather be vaguely right than precisely wrong
por: Bratvold, Reidar Brumer, et al.
Publicado: (2022)

Identification of microRNA signatures in umbilical cord blood associated with maternal characteristics
por: Juracek, Jaroslav, et al.
Publicado: (2019)

The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Effects of Sunitinib and Other Kinase Inhibitors on Cells Harboring a PDGFRB Mutation Associated with Infantile Myofibromatosis
por: Sramek, Martin, et al.
Publicado: (2018)

Case report: rapid and durable response to PDGFR targeted therapy in a child with refractory multiple infantile myofibromatosis and a heterozygous germline mutation of the PDGFRB gene
por: Mudry, Peter, et al.
Publicado: (2017)

Second primary malignancies in colorectal cancer patients
por: Halamkova, Jana, et al.
Publicado: (2021)

Detection of let-7 miRNAs in urine supernatant as potential diagnostic approach in non-metastatic clear-cell renal cell carcinoma
por: Fedorko, Michal, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_46ud5rgtqb60nhs04i08fd2336